Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion type Assertion NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_head.
- NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion description "[However, it cannot be excluded that at the dose used, metoprolol had lost its relative cardio-selectivity and that the reduction in tremor was mediated by competitive antagonism at beta-2 receptor sites in skeletal muscle.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_provenance.
- NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion evidence source_evidence_literature NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_provenance.
- NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion SIO_000772 7031187 NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_provenance.
- NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion wasDerivedFrom befree-2016 NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_provenance.
- NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_assertion wasGeneratedBy ECO_0000203 NP1307509.RA7rNz55ZYlBIcT_FkKeKYv_j6TR0DQAofeiX1YjCHnLg130_provenance.